MARKET

ALVOW

ALVOW

Alvotech
NASDAQ
0.4475
0.0000
0.00%
Closed 09:30 02/06 EST
OPEN
0.4475
PREV CLOSE
0.4475
HIGH
0.4475
LOW
0.4475
VOLUME
1
TURNOVER
--
52 WEEK HIGH
3.000
52 WEEK LOW
0.4100
MARKET CAP
--
P/E (TTM)
2.139
1D
5D
1M
3M
1Y
5Y
1D
Alvotech Reports Positive Results for Biosimilar Entyvio in Pivotal Study
Reuters · 2d ago
Alvotech meldet erfolgreiche Ergebnisse einer PK-Studie für Biosimilar zu Entyvio
Reuters · 2d ago
ALVOTECH ANNOUNCES POSITIVE TOP-LINE RESULTS FROM PIVOTAL PHARMACOKINETIC STUDY FOR PROPOSED BIOSIMILAR TO ENTYVIO®
Reuters · 2d ago
ALVOTECH SA - STUDY MET ALL PRIMARY ENDPOINTS FOR AVT80
Reuters · 2d ago
Weekly Report: what happened at ALVOW last week (0126-0130)?
Weekly Report · 5d ago
Alvotech Signs Biosimilar Supply and Commercialization Agreements with Sandoz for Canada, Australia, and New Zealand
Reuters · 5d ago
ALVOTECH ENTERS SUPPLY AND COMMERCIALIZATION AGREEMENTS FOR CANADA AND AUSTRALIA & NEW ZEALAND COVERING MULTIPLE BIOSIMILAR CANDIDATES
Reuters · 5d ago
ALVOTECH SA - REACHES SETTLEMENT AGREEMENT WITH REGENERON AND BAYER
Reuters · 01/29 08:00
More
About ALVOW
Alvotech SA is a biotechnology company. The Company is focused on the development and manufacture of biosimilar medicines for patients globally. It is engaged in developing a pipeline of monoclonal antibodies that target a variety of therapeutic areas including inflammatory diseases, oncology, and ophthalmology. The Company’s pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Its products pipeline includes AVT02, AVT04, AVT23, AVT03, AVT05, AVT06, AVT16, and AVT33. Its AVT02 is a monoclonal antibody and a biosimilar to Humira (adalimumab). AVT04 is a monoclonal antibody and a biosimilar candidate to Stelara (ustekinumab). It has formed a network of strategic commercial partnerships to provide global reach and leverage expertise in markets that include the United States (U.S.), Europe, Japan, China, and other Asian countries and large parts of South America, Africa, and the Middle East.

Webull offers Alvotech SA stock information, including NASDAQ: ALVOW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALVOW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALVOW stock methods without spending real money on the virtual paper trading platform.